|
|
Vaccine Detail
|
acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Injection [Vaxelis] |
| Vaccine Information |
- Vaccine Name: acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Injection [Vaxelis]
- Target Pathogen: Hepatitis B virus
- Target Disease: Hepatitis B
- Tradename: Vaxelis
- Vaccine Ontology ID: VO_0019377
- Type: inactivated vaccine role|conjugate vaccine role|toxoid vaccine role
- Status: FDA licensed vaccine role
- Host Species for Licensed Use: Human
|
| Host Response |
|
|
| References |
|
|
|
